Works by Imamura, Chiyo K.

Results: 28

Clinical impact of baseline renal function on safety and early discontinuation of adjuvant capecitabine plus oxaliplatin in elderly patients with resected colon cancer: a multicenter post-marketing surveillance study.

Published in:

Japanese Journal of Clinical Oncology, 2020, v. 50, n. 2, p. 122, doi. 10.1093/jjco/hyz149

By:

Yamazaki, Kentaro;
Matsumoto, Shigemi;
Imamura, Chiyo K;
Yamagiwa, Chiemi;
Shimizu, Ayaka;
Yoshino, Takayuki

Publication type:

Article

Concentrations of Irinotecan and SN-38 in the Ascites and the Fluid Product of Cell-Free and Concentrated Ascites Reinfusion Therapy 9 Days After Administration of Irinotecan in a Patient with Gastric Cancer: A Case Report.

Published in:

OncoTargets & Therapy, 2024, v. 17, p. 1089, doi. 10.2147/OTT.S486272

By:

Baba, Keisuke;
Tanie, Tomoki;
Matsubara, Yasuo;
Hirata, Yoshihiro;
Ikematsu, Hiroaki;
Imamura, Chiyo K;
Boku, Narikazu

Publication type:

Article

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.

Published in:

BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-964

By:

Yuji Miura;
Chiyo K Imamura;
Koya Fukunaga;
Yoshihiko Katsuyama;
Koichi Suyama;
Toshikazu Okaneya;
Taisei Mushiroda;
Yuichi Ando;
Toshimi Takano;
Yusuke Tanigawara

Publication type:

Article

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.

Published in:

2014

By:

Miura, Yuji;
Imamura, Chiyo K;
Fukunaga, Koya;
Katsuyama, Yoshihiko;
Suyama, Koichi;
Okaneya, Toshikazu;
Mushiroda, Taisei;
Ando, Yuichi;
Takano, Toshimi;
Tanigawara, Yusuke

Publication type:

journal article

Application of PBPK Modeling and Virtual Clinical Study Approaches to Predict the Outcomes of CYP2D6 Genotype-Guided Dosing of Tamoxifen.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2018, v. 7, n. 7, p. 474, doi. 10.1002/psp4.12307

By:

Nakamura, Toshimichi;
Toshimoto, Kota;
Lee, Wooin;
Imamura, Chiyo K.;
Tanigawara, Yusuke;
Sugiyama, Yuichi

Publication type:

Article

A phase I/II trial evaluating the safety of increased-dose S- 1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancer.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14084-1

By:

Baba, Keisuke;
Suzuki, Nobumi;
Imamura, Chiyo K.;
Booka, Eisuke;
Takeuchi, Masashi;
Takahari, Daisuke;
Kawakami, Takeshi;
Kawakubo, Hirofumi;
Kitagawa, Chiyoe;
Kono, Yoshiyasu;
Ogura, Keiji;
Kito, Yosuke;
Saito, Kei;
Yamamoto, Shinzo;
Takeuchi, Hiroya;
Kudo, Toshihiro;
Tsunoda, Takuya;
Mizukami, Takuro;
Yamaguchi, Toshifumi;
Shoji, Hirokazu

Publication type:

Article

Pharmacokinetics, Efficacy and Safety of Bosutinib in a Pediatric Patient With Chronic Myeloid Leukemia.

Published in:

Journal of Pediatric Pharmacology & Therapeutics, 2020, v. 25, n. 8, p. 742, doi. 10.5863/1551-6776-25.8.742

By:

Akiko Inoue;
Chiyo K. Imamura;
Hiroyuki Shimada;
Daisuke Katayama;
Keisuke Urabe;
Ryo Suzuki;
Kimitaka Takitani;
Akira Ashida

Publication type:

Article

Prospective evaluation and refinement of an S‐1 dosage formula based on renal function for clinical application.

Published in:

Cancer Science, 2021, v. 112, n. 2, p. 751, doi. 10.1111/cas.14758

By:

Takeuchi, Masashi;
Imamura, Chiyo K.;
Booka, Eisuke;
Takeuchi, Hiroya;
Mizukami, Takuro;
Kawakami, Takeshi;
Funakoshi, Taro;
Wakuda, Kazushige;
Aoki, Yu;
Hamamoto, Yasuo;
Kitago, Minoru;
Kawakubo, Hirofumi;
Boku, Narikazu;
Tanigawara, Yusuke;
Kitagawa, Yuko

Publication type:

Article

Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.

Published in:

Cancer Science, 2017, v. 108, n. 9, p. 1843, doi. 10.1111/cas.13309

By:

Otsubo, Kohei;
Nosaki, Kaname;
Imamura, Chiyo K.;
Ogata, Hiroaki;
Fujita, Akitaka;
Sakata, Shinya;
Hirai, Fumihiko;
Toyokawa, Gouji;
Iwama, Eiji;
Harada, Taishi;
Seto, Takashi;
Takenoyama, Mitsuhiro;
Ozeki, Takeshi;
Mushiroda, Taisei;
Inada, Mieko;
Kishimoto, Junji;
Tsuchihashi, Kenji;
Suina, Kentaro;
Nagano, Osamu;
Saya, Hideyuki

Publication type:

Article

Prospective evaluation of the relationship between response and exposure of total and unbound erlotinib in non-small cell lung cancer patients.

Published in:

2022

By:

Kenmotsu, Hirotsugu;
Imamura, Chiyo K.;
Kawamura, Takahisa;
Oyakawa, Takuya;
Omori, Shota;
Nakashima, Kazuhisa;
Wakuda, Kazushige;
Ono, Akira;
Taira, Tetsuhiko;
Naito, Tateaki;
Murakami, Haruyasu;
Yamamoto, Nobuyuki;
Takahashi, Toshiaki;
Tanigawara, Yusuke

Publication type:

journal article

Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity.

Published in:

2020

By:

Kawamura, Takahisa;
Imamura, Chiyo K.;
Kenmotsu, Hirotsugu;
Taira, Tetsuhiko;
Omori, Shota;
Nakashima, Kazuhisa;
Wakuda, Kazushige;
Ono, Akira;
Naito, Tateaki;
Murakami, Haruyasu;
Mushiroda, Taisei;
Takahashi, Toshiaki;
Tanigawara, Yusuke

Publication type:

journal article

Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole.

Published in:

Journal of Clinical Pharmacology, 2016, v. 56, n. 4, p. 408, doi. 10.1002/jcph.605

By:

Imamura, Chiyo K.;
Furihata, Kenichi;
Okamoto, Shinichiro;
Tanigawara, Yusuke

Publication type:

Article

A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese.

Published in:

Human Molecular Genetics, 2012, v. 21, n. 7, p. 1665, doi. 10.1093/hmg/ddr597

By:

Kiyotani, Kazuma;
Mushiroda, Taisei;
Tsunoda, Tatsuhiko;
Morizono, Takashi;
Hosono, Naoya;
Kubo, Michiaki;
Tanigawara, Yusuke;
Imamura, Chiyo K.;
Flockhart, David A.;
Aki, Fuminori;
Hirata, Koichi;
Takatsuka, Yuichi;
Okazaki, Minoru;
Ohsumi, Shozo;
Yamakawa, Takashi;
Sasa, Mitsunori;
Nakamura, Yusuke;
Zembutsu, Hitoshi

Publication type:

Article

Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.

Published in:

2025

By:

Nakashima, Kazuhisa;
Harashima, Saki;
Kaneko, Rena;
Tanaka, Ryuhei;
Abe, Masakazu;
Wada, Makoto;
Iino, Keiko;
Akechi, Tatsuo;
Iihara, Hirotoshi;
Imamura, Chiyo K.;
Okuyama, Ayako;
Ozawa, Keiko;
Kim, Yong-il;
Satomi, Eriko;
Takeda, Masayuki;
Nakajima, Takako Eguchi;
Nakamura, Naoki;
Nishimura, Junichi;
Noda, Mayumi;
Hayashi, Kazumi

Publication type:

Literature Review

Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology

Published in:

2025

By:

Murakami, Michiyasu;
Miyata, Yoshiharu;
Nakashima, Kazuhisa;
Abe, Masakazu;
Nishimura, Junichi;
Wada, Makoto;
Iino, Keiko;
Akechi, Tatsuo;
Iihara, Hirotoshi;
Imamura, Chiyo K.;
Okuyama, Ayako;
Ozawa, Keiko;
Kim, Yong-il;
Sasaki, Hidenori;
Satomi, Eriko;
Takeda, Masayuki;
Tanaka, Ryuhei;
Nakamura, Naoki;
Noda, Mayumi;
Hayashi, Kazumi

Publication type:

Literature Review

Defining the clinical benefits of adding a neurokinin-1 receptor antagonist to control chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a systematic review and meta-analysis of the clinical practice guidelines for antiemesis 2023 from the Japan society of clinical oncology

Published in:

International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1616, doi. 10.1007/s10147-024-02623-y

By:

Hayashi, Toshinobu;
Yamamoto, Shun;
Miyata, Yoshiharu;
Takeda, Masayuki;
Abe, Masakazu;
Wada, Makoto;
Iino, Keiko;
Akechi, Tatsuo;
Imamura, Chiyo K.;
Okuyama, Ayako;
Ozawa, Keiko;
Kim, Yong-Il;
Sasaki, Hidenori;
Satomi, Eriko;
Tanaka, Ryuhei;
Nakajima, Takako Eguchi;
Nakamura, Naoki;
Nishimura, Junichi;
Noda, Mayumi;
Hayashi, Kazumi

Publication type:

Article

Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology

Published in:

International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1632, doi. 10.1007/s10147-024-02624-x

By:

Yokomizo, Ayako;
Nakashima, Kazuhisa;
Iba, Arisa;
Okita, Kenji;
Wada, Makoto;
Iino, Keiko;
Akechi, Tatsuo;
Iihara, Hirotoshi;
Imamura, Chiyo K.;
Okuyama, Ayako;
Ozawa, Keiko;
Kim, Yong-Il;
Sasaki, Hidenori;
Satomi, Eriko;
Takeda, Masayuki;
Tanaka, Ryuhei;
Nakajima, Takako Eguchi;
Nakamura, Naoki;
Nishimura, Junichi;
Noda, Mayumi

Publication type:

Article

Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology

Published in:

International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1785, doi. 10.1007/s10147-024-02643-8

By:

Nakashima, Kazuhisa;
Yokomizo, Ayako;
Murakami, Michiyasu;
Okita, Kenji;
Wada, Makoto;
Iino, Keiko;
Akechi, Tatsuo;
Iihara, Hirotoshi;
Imamura, Chiyo K.;
Okuyama, Ayako;
Ozawa, Keiko;
Kim, Yong-il;
Sasaki, Hidenori;
Satomi, Eriko;
Takeda, Masayuki;
Tanaka, Ryuhei;
Nakajima, Takako Eguchi;
Nakamura, Naoki;
Nishimura, Junichi;
Noda, Mayumi

Publication type:

Article

Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.

Published in:

International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 889, doi. 10.1007/s10147-024-02536-w

By:

Kobayashi, Masamitsu;
Kako, Jun;
Iba, Arisa;
Okuyama, Ayako;
Ozawa, Keiko;
Abe, Masakazu;
Wada, Makoto;
Akechi, Tatsuo;
Iihara, Hirotoshi;
Imamura, Chiyo K.;
Kim, Yong-Il;
Sasaki, Hidenori;
Satomi, Eriko;
Takeda, Masayuki;
Tanaka, Ryuhei;
Nakajima, Takako Eguchi;
Nakamura, Naoki;
Nishimura, Junichi;
Noda, Mayumi;
Hayashi, Kazumi

Publication type:

Article

2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.

Published in:

International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x

By:

Iihara, Hirotoshi;
Abe, Masakazu;
Wada, Makoto;
Iino, Keiko;
Akechi, Tatsuo;
Imamura, Chiyo K.;
Okuyama, Ayako;
Ozawa, Keiko;
Kim, Yong-Il;
Sasaki, Hidenori;
Satomi, Eriko;
Takeda, Masayuki;
Tanaka, Ryuhei;
Nakajima, Takako Eguchi;
Nakamura, Naoki;
Nishimura, Junichi;
Noda, Mayumi;
Hayashi, Kazumi;
Higashi, Takahiro;
Boku, Narikazu

Publication type:

Article

Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis.

Published in:

International Journal of Clinical Oncology, 2021, v. 26, n. 1, p. 1, doi. 10.1007/s10147-020-01818-3

By:

Aogi, Kenjiro;
Takeuchi, Hideki;
Saeki, Toshiaki;
Aiba, Keisuke;
Tamura, Kazuo;
Iino, Keiko;
Imamura, Chiyo K.;
Okita, Kenji;
Kagami, Yoshikazu;
Tanaka, Ryuhei;
Nakagawa, Kazuhiko;
Fujii, Hirofumi;
Boku, Narikazu;
Wada, Makoto;
Akechi, Tatsuo;
Iihara, Hirotoshi;
Ohtani, Shoichiro;
Okuyama, Ayako;
Ozawa, Keiko;
Kim, Yong-Il

Publication type:

Article

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV.

Published in:

International Journal of Clinical Oncology, 2019, v. 24, n. 7, p. 731, doi. 10.1007/s10147-019-01431-z

By:

Akamatsu, Hiroaki;
Ninomiya, Kiichiro;
Kenmotsu, Hirotsugu;
Morise, Masahiro;
Daga, Haruko;
Goto, Yasushi;
Kozuki, Toshiyuki;
Miura, Satoru;
Sasaki, Takaaki;
Tamiya, Akihiro;
Teraoka, Shunsuke;
Tsubata, Yukari;
Yoshioka, Hiroshige;
Hattori, Yoshihiro;
Imamura, Chiyo K.;
Katsuya, Yuki;
Matsui, Reiko;
Minegishi, Yuji;
Mizugaki, Hidenori;
Nosaki, Kaname

Publication type:

Article

A double‐blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy‐induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide

Published in:

Cancer Medicine, 2020, v. 9, n. 10, p. 3319, doi. 10.1002/cam4.2979

By:

Matsumoto, Koji;
Takahashi, Masato;
Sato, Kazuhiko;
Osaki, Akihiko;
Takano, Toshimi;
Naito, Yoichi;
Matsuura, Kazuo;
Aogi, Kenjiro;
Fujiwara, Kimiko;
Tamura, Kenji;
Baba, Motoi;
Tokunaga, Shinya;
Hirano, Gen;
Imoto, Shigeru;
Miyazaki, Chieko;
Yanagihara, Kazuhiro;
Imamura, Chiyo K.;
Chiba, Yasutaka;
Saeki, Toshiaki

Publication type:

Article

The effects of advanced age and serum α1-acid glycoprotein on docetaxel unbound exposure and dose-limiting toxicity in cancer patients.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 11, p. 2416, doi. 10.1111/bcp.13354

By:

Kenmotsu, Hirotsugu;
Imamura, Chiyo K.;
Ono, Akira;
Omori, Shota;
Nakashima, Kazuhisa;
Wakuda, Kazushige;
Taira, Tetsuhiko;
Naito, Tateaki;
Murakami, Haruyasu;
Takahashi, Toshiaki;
Tanigawara, Yusuke

Publication type:

Article

Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (PARADISE-1): a phase I trial.

Published in:

BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12653-4

By:

Hirata, Kenro;
Yoshida, Kayo;
Katada, Chikatoshi;
Watanabe, Akinori;
Tsushima, Takahiro;
Yamaguchi, Toshifumi;
Yamamoto, Sachiko;
Ishikawa, Hideki;
Sato, Yasunori;
Imamura, Chiyo K.;
Tanigawara, Yusuke;
Ito, Yoshinori;
Kato, Ken;
Kitagawa, Yuko;
Hamamoto, Yasuo

Publication type:

Article

A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial).

Published in:

2020

By:

Takeshi Suzuki;
Yasutaka Sukawa;
Imamura, Chiyo K.;
Toshiki Masuishi;
Hironaga Satake;
Yosuke Kumekawa;
Shinsuke Funakoshi;
Masahito Kotaka;
Yoshiki Horie;
Sadayuki Kawai;
Hiroyuki Okuda;
Tetsuji Terazawa;
Chihiro Kondoh;
Ken Kato;
Kenichi Yoshimura;
Hideki Ishikawa;
Yasuo Hamamoto;
Narikazu Boku;
Hiromasa Takaishi;
Takanori Kanai

Publication type:

journal article

Evaluation of clinical validity of an S-1 dosage formula based on renal function using data of the SPIRITS and the G-SOX trials.

Published in:

Gastric Cancer, 2022, v. 25, n. 4, p. 770, doi. 10.1007/s10120-022-01291-z

By:

Booka, Eisuke;
Imamura, Chiyo K.;
Takeuchi, Masashi;
Kawakubo, Hirofumi;
Takeuchi, Hiroya;
Tanigawara, Yusuke;
Kitagawa, Yuko;
Boku, Narikazu

Publication type:

Article

Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.

Published in:

2020

By:

Hirata, Kenro;
Hamamoto, Yasuo;
Ando, Masahiko;
Imamura, Chiyo K.;
Yoshimura, Kenichi;
Yamazaki, Kentaro;
Hironaka, Shuichi;
Muro, Kei

Publication type:

journal article